January 12, 2026 - 07:42

In a bold move, Shopify CEO Tobi Lutke has addressed government officials and ministers regarding the proposed ban on the social media platform X, owned by Elon Musk, as well as the AI chatbot Grok. Lutke described the discussions circulating among the UK, Canada, and Australia as a “great hoax,” expressing his discontent with the idea of restricting access to these platforms.
Lutke's message underscores a growing concern within the technology sector about the implications of such a ban on innovation and free speech. He argues that limiting access to influential platforms like X could stifle communication and hinder the exchange of ideas, which are essential for technological advancement.
The CEO's remarks reflect a broader debate about the role of social media in society and the responsibilities of tech companies in regulating content. As discussions continue, Lutke's stance highlights the tension between government regulation and the autonomy of digital platforms in the evolving landscape of technology.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...